Medipharm Labs Corp T.LABS

DEA/FDA

[Solid1]

So the DEA has recognized the FDA's new evaluation method as legitimate! That was the last hurdle, what else stands in the way of new cannabis-based medicines? The problem has always been that the DEA had the final say because cannabis was on Schedule 1 and could not be marketed without DEA approval despite FDA approval. At least that was my understanding of the problem. I expect approvals soon

[Solid1]

Patent disputes over Epidiolex are also worthless.... Everyone only wanted Epidiolex because the DEA took it off the list completely while regular CBD remained in Schedule 1. 

[QContinuum1]

If this were true, then the judge would have thrown out the case long ago.  The judge has not done so, so therefore the patent disputes are not worthless.

[Solid1]

But of course, if the DEA removes new approvals from the list, as it did with Epidiolex, then Epidiolex is no longer the gold standard for CBD medications and therefore no longer worth pursuing